Discover 1,955 paid clinical trials in Denton, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,955
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
for
Atopic Dermatitis
Location: Dallas TX, Pflugerville TX, Sugar Land TX, Bolivar MO,
Sponsor: Sanofi
Sex: All
Age: 12+
Code: NCT07290803
Recruiting
A Clinical Trial to Evaluate a Corneal Inlay for the Improvement of Near and Intermediate Vision in Pseudophakic Presbyopic Subjects
for
Presbyopia, Pseudophakia
Location: Dallas TX, Houston TX, San Antonio TX, Sioux Falls SD,
Sponsor: ReVision Optics, Inc.
Sex: All
Age: 50+
Code: NCT02668523
Phase 3, Recruiting
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
for
Eosinophilic Asthma
Location: Dallas TX, McKinney TX, Edmond OK, Kansas City KS,
Sponsor: Kymera Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07323654
Phase 2, Recruiting
A Long-term Study of KT-621 Administered Orally to Participants With Asthma Previously Enrolled in a KT-621 Asthma Study
for
Asthma (Diagnosis)
Location: Dallas TX, Tampa FL, Miami FL
Sponsor: Kymera Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07677059
Phase 2, Recruiting
Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
for
Open Angle Glaucoma (OAG)
Location: Dallas TX, Houston TX, Grand Junction CO, Kenosha WI,
Sponsor: Avisi Technologies Inc.
Sex: All
Age: 45+
Code: NCT07220876
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMSĀ®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
for
Primary Open Angle Glaucoma, Open Angle Glaucoma
Location: Dallas TX
Sponsor: Sanoculis Ltd
Sex: All
Age: 40 - 70+
Code: NCT06313749
Recruiting
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: Dallas TX, Austin TX, Houston TX, Little Rock AR,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06545955
Phase 3, Recruiting
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Dallas TX, Austin TX, Houston TX, Little Rock AR,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06510374
Phase 3, Recruiting
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
for
Metastatic Castration Resistant Prostate Cancer
Location: Dallas TX, Fort Worth TX, Houston TX, Nashville TN,
Sponsor: ORIC Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT07723248
Phase 3, Recruiting
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer